Skip to main content
Clinical Trials/NCT02792361
NCT02792361
Unknown
Not Applicable

A Randomized, Non-Blind, Clinical Effectiveness Trial in Post-Operative Pterional Craniotomy Drain Placement

University of Arizona0 sites90 target enrollmentJune 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pterional Craniotomy
Sponsor
University of Arizona
Enrollment
90
Primary Endpoint
Pain Difference
Last Updated
9 years ago

Overview

Brief Summary

This is a clinical trial where patients who present to the neurosurgery service in need of a procedure that requires a pterional craniotomy will be screened, and if eligible, enrolled for the randomization in the placement of a drain at the surgical site. At present, there is not a protocol for whether or not to use a drain following this procedure. There is some debate on whether it serves any real benefit for the patient or if it may actually be detrimental in cases where infection occurs. This study aims to answer this question by randomizing patients to drain placement and then comparing patient outcomes between the two groups. These include the following: infection rate, length of hospital stay, self-reported patient pain and discomfort, the amount of time before patients are able to open their eye ipsilateral to the side of operation, change in forehead circumference post-op days 1-3, and any unforeseen post-operative complications. This will be accomplished through using a patient-administered survey, recording physical measurements, and a patient chart review. Statistical analysis will then be used to identify any differences that may exist.

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
June 2019
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Wyatt Ramey

Medical Doctor

University of Arizona

Eligibility Criteria

Inclusion Criteria

  • Patients that have been scheduled for surgery requiring the use of a pterional craniotomy approach

Exclusion Criteria

  • Patients in need of a surgical intervention requiring a pterional craniotomy due to reasons of physical injury
  • Patients who need a pterional craniotomy with a orbitozygomatic approach
  • Patients who have noticeable physical injury to their skull
  • Patients with a prior surgical history of a craniotomy
  • Patients with a pathological condition deemed severe enough by the screening physician to possibly influence the healing process of the procedure (blood clot disorder, cirrhosis, severe nutrient depletion, congestive heart failure etc.)

Outcomes

Primary Outcomes

Pain Difference

Time Frame: At the time of discharge from the hospital but no longer than up to 16 weeks from the date of surgery.

Compare the reported pain/ discomfort between the patients who had drain placement from those who did not. This will be performed using a survey administered to patients upon removal of the drain

Complication Rate

Time Frame: From the date of surgery to the date of discharge from the hospital for up to 16 weeks following surgery, or until death, depending which comes first.

An overall assessment comparing complications between the two study groups will be performed. This will include looking things such as hospital acquired pneumonia, the development of any new neurological conditions or deficiencies, and other unforeseen complications that may arise which are not be directly related to the drain but may potentially still be influenced by it.

Surgical site infection rate

Time Frame: From the date of surgery to the date of discharge from the hospital for up to 16 weeks following surgery, or until death, depending which comes first.

Compare infections rates between patients with drains placement versus those who did not. Determine if there is any statistically significant difference in risk exists between the two study populations.

Difference in Length of Hospital Stay

Time Frame: From the date of surgery to the date of discharge from the hospital for up to 16 weeks following surgery, or until death, depending which comes first.

Compare the length of hospital between the treatment groups and determine whether a significant difference exists.

Head Circumference Difference

Time Frame: Day 1 through Day 3 following surgery.

Compare the change in measured forehead circumference between treatment groups on post-operative days 1-3. Determine if a significant difference exists between the two.

Ability to open ipsilateral eye to surgical site.

Time Frame: Day 1 through Day 3 following surgery.

Compare the number of subjects able to open and close their eye on the ipsilateral side of the surgical site between the study groups

Similar Trials